Our goal is to develop new therapies for the treatment of patients with blood cancers. Our research focuses on understanding the biology of cancer cells and the biology of lymphocytes that have the ability to eliminate the cancer cells. In addition, we develop novel biologics such as engineered antibodies and cell therapies that can kill cancer cells, while sparing the healthy tissues.
Cell therapies including CAR T cells and bone marrow transplant represent a revolutionary approach in cancer therapy. Cell therapies utilize living immune cells to eliminate cancer cells with remarkable precision. We engineer cell therapies with the goal of treating a range of hematologic cancers.